SGEN Financial Facts
Net income (loss): -16.26MIncome (loss) from operations: -16.39M
See Full Income Statement
Prepaid expenses and other current assets: 7.19M
Total stockholders' equity: 233.27M
See Full Balance Sheet
Earnings History for Seattle Genetics Inc. (SGEN)
|
Expand Research on SGEN
| Next EPS Date | 8/7/13 *Est. | EPS Growth Rate | -27.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +17.0% | Revenue Growth Rate | +18.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | +2.1% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/13 |
Q113 | -$0.14 | -$0.20 | +$0.06 | $57.3M | $53.72M | N/A / N/A | N/A | -1.3% | Details | |
| 2/12/13 |
Q412 | -$0.09 | -$0.11 | +$0.02 | $35.35M | $57.21M | N/A / N/A | N/A | +19.5% | Details | |
| 11/7/12 |
Q312 | -$0.12 | -$0.15 | +$0.03 | $49.8M | $52.66M | $-0.13 / $52.84M | N/A | +42.8% | Details | |
| 8/8/12 |
Q212 | -$0.15 | -$0.15 | $0.00 | $48.8M | $50.33M | N/A / N/A | N/A | +46.4% | Details | |
| 5/8/12 |
Q112 | -$0.11 | -$0.12 | +$0.01 | $48.2M | $52.33M | N/A / N/A | N/A | +83.7% | Details | |
| 2/13/12 |
Q411 | -$0.24 | -$0.31 | +$0.07 | $48.9M | $39.12M | N/A / N/A | N/A | +83.9% | Details | |
| 11/3/11 |
Q311 | -$0.35 | -$0.46 | +$0.11 | $20M | $13.57M | N/A / N/A | = | +59.2% | Details | |
| 8/4/11 |
Q211 | -$0.45 | -$0.39 | -$0.06 | $13.1M | $10.97M | N/A / N/A | = | +143.7% | Details |
